Invention Publication
- Patent Title: 18F - TAGGED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) AND THEIR USE AS IMAGING AGENTS FOR PROSTATE CANCER
-
Application No.: US18186043Application Date: 2023-03-17
-
Publication No.: US20230295092A1Publication Date: 2023-09-21
- Inventor: Jens Cardinale , Martin Schaefer , Klaus Kopka , Matthias Eder , Ulrike Bauder-Wuest , Michael Eisenhut , Martina Benesova , Uwe Haberkorn , Frederik L. Giesel
- Applicant: DEUTSCHES KREBSFORSCHUNGSZENTRUM , RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG
- Applicant Address: DE Heidelberg
- Assignee: DEUTSCHES KREBSFORSCHUNGSZENTRUM,RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG
- Current Assignee: DEUTSCHES KREBSFORSCHUNGSZENTRUM,RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG
- Current Assignee Address: DE Heidelberg
- Priority: EP 002800.9 2015.09.30 EP 164090.9 2016.04.06 EP 182764.7 2016.08.04
- Main IPC: C07D213/61
- IPC: C07D213/61 ; A61K51/04 ; C07B59/00 ; G01N33/574 ; C07K7/02 ; A61P35/00
Abstract:
The present invention generally relates to the field of radiopharmaceuticals and their use in nuclear medicine as tracers and imaging agents for various disease states of prostate cancer.
Public/Granted literature
- US12054458B2 Public/Granted day:2024-08-06
Information query
